Innovative Therapeutic Strategies for the Treatment of Repeated Implantation Failure: An Update
February 2023
in “
Acta Scientific Women s Health
”
Studysummary This review examines emerging and past therapies for recurrent implantation failure, focusing on three innovative strategies: PBMC, G-CSF, and PRP, but reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discussed innovative therapeutic strategies for treating Recurrent Implantation Failure (RIF), focusing on three promising approaches: the use of peripheral blood mononuclear cells (PBMC), subcutaneous administration of Granulocyte Colony-Stimulating Factor (G-CSF), and platelet-rich plasma (PRP). These strategies were highlighted as attractive options for aiding RIF patients. Additionally, the document reviewed other immune therapies used in the past, such as intrauterine insemination of hCG, intravenous immunoglobulins (IVIG), intravenous intralipid, and heparin, detailing their mechanisms of action.
